Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Income Statement

Last quarter (Q1 2025), Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total revenue was zł13.43M, a decrease of -3.41% from the same quarter last year. In Q1, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s net income was zł-538.00K. See Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s key income statements, including revenue, expenses, profit, and income.